HEADER SUGAR BINDING PROTEIN 30-MAY-10 2XG3 TITLE HUMAN GALECTIN-3 IN COMPLEX WITH A BENZAMIDO-N-ACETYLLACTOSEAMINE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 114-250; COMPND 5 SYNONYM: GAL-3,35 KDA LECTIN,CARBOHYDRATE-BINDING PROTEIN 35,CBP 35, COMPND 6 GALACTOSE-SPECIFIC LECTIN 3,GALACTOSIDE-BINDING PROTEIN,GALBP,IGE- COMPND 7 BINDING PROTEIN,L-31,LAMININ-BINDING PROTEIN,LECTIN L-29,MAC-2 COMPND 8 ANTIGEN; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS3, MAC2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PLYSS STAR KEYWDS IGE-BINDING PROTEIN, LECTIN, SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.DIEHL,O.ENGSTROM,T.DELAINE,M.HAKANSSON,S.GENHEDEN,K.MODIG, AUTHOR 2 H.LEFFLER,U.RYDE,U.NILSSON,M.AKKE REVDAT 6 29-JUL-20 2XG3 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 22-MAY-19 2XG3 1 REMARK LINK REVDAT 4 05-DEC-18 2XG3 1 COMPND SOURCE JRNL DBREF REVDAT 3 17-JAN-18 2XG3 1 REMARK REVDAT 2 06-JUL-11 2XG3 1 JRNL REMARK REVDAT 1 13-OCT-10 2XG3 0 JRNL AUTH C.DIEHL,O.ENGSTROM,T.DELAINE,M.HAKANSSON,S.GENHEDEN,K.MODIG, JRNL AUTH 2 H.LEFFLER,U.RYDE,U.J.NILSSON,M.AKKE JRNL TITL PROTEIN FLEXIBILITY AND CONFORMATIONAL ENTROPY IN LIGAND JRNL TITL 2 DESIGN TARGETING THE CARBOHYDRATE RECOGNITION DOMAIN OF JRNL TITL 3 GALECTIN-3. JRNL REF J. AM. CHEM. SOC. V. 132 14577 2010 JRNL REFN ESSN 1520-5126 JRNL PMID 20873837 JRNL DOI 10.1021/JA105852Y REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.141 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.139 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2050 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 39025 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.124 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.121 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.174 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1593 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 30159 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1106 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 231 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1364.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1149.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 45 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 13969 REMARK 3 NUMBER OF RESTRAINTS : 19364 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 ANGLE DISTANCES (A) : 0.031 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.037 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.080 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.070 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.022 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.050 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.097 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER G58 REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XG3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1290044116. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAR-09 REMARK 200 TEMPERATURE (KELVIN) : 105 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I911-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.90778 REMARK 200 MONOCHROMATOR : BENT SILICON CRYSTAL REMARK 200 OPTICS : MULTILAYER MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH SX-165 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41094 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -10.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.66000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SHELXL REMARK 200 STARTING MODEL: GALECTIN-3C IN COMPLEX WITH COMPOUND 354 REMARK 200 REMARK 200 REMARK: A HIGHER RESOLUTION STRUCTURE OF GALECTIN TO BE PUBLISHED REMARK 200 WAS USED AS STARTING MODEL IN REFINEMENT WITH DELETED COMPOUND REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 29.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.90000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.20500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.84500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.20500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.90000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.84500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 168 NE - CZ - NH1 ANGL. DEV. = -3.7 DEGREES REMARK 500 ARG A 169 NE - CZ - NH1 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG A 169 NE - CZ - NH2 ANGL. DEV. = -5.3 DEGREES REMARK 500 ARG A 186 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 GLN A 187 C - N - CA ANGL. DEV. = 15.5 DEGREES REMARK 500 TYR A 221 CB - CG - CD2 ANGL. DEV. = 5.1 DEGREES REMARK 500 ARG A 224 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 129 -1.80 89.05 REMARK 500 ARG A 129 7.06 82.67 REMARK 500 ASN A 141 38.49 38.09 REMARK 500 ASN A 164 82.80 -153.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 113 LEU A 114 -142.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2064 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A2095 DISTANCE = 6.61 ANGSTROMS REMARK 525 HOH A2125 DISTANCE = 6.43 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A3K RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF THE HUMAN GALECTIN-3 CARBOHYDRATE REMARK 900 RECOGNITION DOMAIN (CRD) AT 2.1 ANGSTROM RESOLUTION REMARK 900 RELATED ID: 1KJR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN GALECTIN-3 CRD IN COMPLEXWITH A 3'- REMARK 900 DERIVATIVE OF N- ACETYLLACTOSAMINE REMARK 900 RELATED ID: 1KJL RELATED DB: PDB REMARK 900 HIGH RESOLUTION X-RAY STRUCTURE OF HUMAN GALECTIN-3 INCOMPLEX WITH REMARK 900 LACNAC REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CARBOHYDRATE RECOGNITION DOMAIN IN THIS CONSTRUCT REMARK 999 STARTS WITH A114 (INSTEAD OF P114) OTHERWISE IT IS THE REMARK 999 SAME SEQUENCE DBREF 2XG3 A 114 250 UNP P17931 LEG3_HUMAN 114 250 SEQADV 2XG3 ALA A 113 UNP P17931 EXPRESSION TAG SEQRES 1 A 138 ALA LEU ILE VAL PRO TYR ASN LEU PRO LEU PRO GLY GLY SEQRES 2 A 138 VAL VAL PRO ARG MET LEU ILE THR ILE LEU GLY THR VAL SEQRES 3 A 138 LYS PRO ASN ALA ASN ARG ILE ALA LEU ASP PHE GLN ARG SEQRES 4 A 138 GLY ASN ASP VAL ALA PHE HIS PHE ASN PRO ARG PHE ASN SEQRES 5 A 138 GLU ASN ASN ARG ARG VAL ILE VAL CYS ASN THR LYS LEU SEQRES 6 A 138 ASP ASN ASN TRP GLY ARG GLU GLU ARG GLN SER VAL PHE SEQRES 7 A 138 PRO PHE GLU SER GLY LYS PRO PHE LYS ILE GLN VAL LEU SEQRES 8 A 138 VAL GLU PRO ASP HIS PHE LYS VAL ALA VAL ASN ASP ALA SEQRES 9 A 138 HIS LEU LEU GLN TYR ASN HIS ARG VAL LYS LYS LEU ASN SEQRES 10 A 138 GLU ILE SER LYS LEU GLY ILE SER GLY ASP ILE ASP LEU SEQRES 11 A 138 THR SER ALA SER TYR THR MET ILE HET NAG B 1 15 HET GAL B 2 10 HET CL A1252 1 HET UNU A1253 9 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM CL CHLORIDE ION HETNAM UNU BENZAMIDE FORMUL 2 NAG C8 H15 N O6 FORMUL 2 GAL C6 H12 O6 FORMUL 3 CL CL 1- FORMUL 4 UNU C7 H7 N O FORMUL 5 HOH *231(H2 O) HELIX 1 1 LYS A 227 ILE A 231 5 5 SHEET 1 AA 6 TYR A 118 PRO A 121 0 SHEET 2 AA 6 LYS A 233 GLY A 238 -1 O LEU A 234 N LEU A 120 SHEET 3 AA 6 ILE A 145 ARG A 151 -1 O ALA A 146 N SER A 237 SHEET 4 AA 6 ASP A 154 GLU A 165 -1 O ASP A 154 N ARG A 151 SHEET 5 AA 6 ARG A 168 LEU A 177 -1 O ARG A 168 N GLU A 165 SHEET 6 AA 6 ASN A 180 TRP A 181 -1 O ASN A 180 N LEU A 177 SHEET 1 AB 6 TYR A 118 PRO A 121 0 SHEET 2 AB 6 LYS A 233 GLY A 238 -1 O LEU A 234 N LEU A 120 SHEET 3 AB 6 ILE A 145 ARG A 151 -1 O ALA A 146 N SER A 237 SHEET 4 AB 6 ASP A 154 GLU A 165 -1 O ASP A 154 N ARG A 151 SHEET 5 AB 6 ARG A 168 LEU A 177 -1 O ARG A 168 N GLU A 165 SHEET 6 AB 6 GLU A 185 GLN A 187 -1 O GLU A 185 N CYS A 173 SHEET 1 AC 2 ASN A 180 TRP A 181 0 SHEET 2 AC 2 ARG A 168 LEU A 177 -1 O LEU A 177 N ASN A 180 SHEET 1 AD 5 ALA A 216 ASN A 222 0 SHEET 2 AD 5 HIS A 208 VAL A 213 -1 O PHE A 209 N TYR A 221 SHEET 3 AD 5 PRO A 197 VAL A 204 -1 O GLN A 201 N ALA A 212 SHEET 4 AD 5 MET A 130 VAL A 138 -1 O MET A 130 N VAL A 204 SHEET 5 AD 5 ILE A 240 MET A 249 -1 O ASP A 241 N THR A 137 LINK N09 UNU A1253 C3 GAL B 2 1555 1555 1.45 LINK O4 NAG B 1 C1 GAL B 2 1555 1555 1.43 CISPEP 1 VAL A 116 PRO A 117 0 -0.50 CISPEP 2 VAL A 116 PRO A 117 0 -0.10 CRYST1 35.800 57.690 62.410 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027933 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017334 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016023 0.00000